Cost-effectiveness of meningococcal vaccination of infants in the Russian Federation

Cost-effectiveness of meningococcal vaccination of infants in the Russian Federation

Generalized forms of invasive meningococcal desease (IMD) are very dangerous because they have a high mortality rate.The aim of the work was to assess the cost-effectiveness of meningococcal vaccination of infants with the 4-valent MenACWY-D conjugate vaccine in the Russian Federation.Material and m...

Full description

Bibliographic Details
Main Authors:	A. V. Rudakova, A. A. Vilnits, S. M. Kharit, Yu. V. Lobzin
Format:	Article
Language:	Russian
Published:	Journal Infectology 2021-12-01
Series:	Журнал инфектологии
Subjects:	менингококковая инфекция 4-валентная вакцина дети эффективность затрат
Online Access:	https://journal.niidi.ru/jofin/article/view/1277

Similar Items

INFLUENZA VACCINATION OF CHILDREN OF PRESCHOOL AGE IN THE RUSSIAN FEDERATION: COST-EFFECTIVENESS OF QUADRIVALENT VACCINE
by: A. V. Rudakova, et al.
Published: (2019-03-01)

Pharmacoeconomic aspects of vaccination against Pneumococcal Infection in Russia
by: A. V. Rudakova, et al.
Published: (2014-09-01)

PHARMACOECONOMIC ASSESSMENT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN IMMUNIZATION OF CHILDREN IN RUSSIAN FEDERATION
by: A. V. Rudakova, et al.
Published: (2014-01-01)

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) in Children 9–23 Months of Age in Russian Federation: Results of Russian Part of International Study in Russia and India
by: O. A. Perminova, et al.
Published: (2020-05-01)

Сost-effectiveness of pentavalent rotavirus vaccination in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2023-01-01)

Safety of Combination of a Tetravalent Meningococcal Conjugate Vaccine Against Serogroups A, C, Y, W-135 With Other Vaccine Preparations: a Prospective Study of a Series of Cases Among Healthy Children and Children With Various Health Abnormalities
by: Leyla S. Namazova-Baranova, et al.
Published: (2017-06-01)

The Safety of 4-valent Meningococcal Conjugate Vaccine in Two Years Old Children: Prospective Cohort Study in Sakhalin Region
by: Oxana V. Solonina, et al.
Published: (2019-09-01)

Clinical and epidemiological aspects of generalized meningococcal infections in children and adolescents of Saint-Petersburg
by: Yu. V. Lobzin, et al.
Published: (2016-04-01)

World Experience in the Use Serogroup B Meningococcal Vaccines (literature review)
by: I. S. Koroleva, et al.
Published: (2022-01-01)

Vaccination against Pneumococcal Infections of High-Risk People: Pharmacoeconomic Aspects
by: A. V. Rudakova, et al.
Published: (2020-01-01)

Meningococcal infection in children: factors influencing outcome
by: O. V. Samodova, et al.
Published: (2019-10-01)

Clinical-epidemiological features of meningococcal infection in children during sporadic morbidity
by: G. P. Martynova, et al.
Published: (2015-07-01)

Cost-effectiveness of vaccination against pneumococcal infection of adults at risk within the federal and regional programs
by: A. V. Rudakova, et al.
Published: (2019-12-01)

Observational Safety Study of Meningococcal Conjugate Vaccine Against Serogroups A, C, W and Y (Menactra) Used in Routine Healthcare Practice for Persons Aged 2 to 55 Years in Russian Federation
by: I. Ya. Izvekova, et al.
Published: (2019-01-01)

Cost effectiveness analysis of universal varicella vaccination in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2021-10-01)

The Course of Generalized Meningococcal Infection Caused by Meningococcus Serogroup W135
by: M. V. Ivanova, et al.
Published: (2016-11-01)

Epidemiology and Regional Programs on Meningococcal Disease Prevention in Tyumen Region and Yamalo-Nenets Autonomous District
by: Olga A. Richkova, et al.
Published: (2020-06-01)

Herpesviruses, as a possible cause complicated course of invasive meningococcal disease (clinical case)
by: N. V. Skripchenko, et al.
Published: (2016-07-01)

VACCINATION AGAINST PNEUMOCOCCAL INFECTIONS IN RUSSIAN FEDERATION: SOCIAL AND PHARMACOECONOMIC ASPECTS
by: A. V. Rudakova, et al.
Published: (2018-10-01)

MENINGOCOCCAL INFECTION IN CHILDREN IN KIROV REGION
by: T. V. Egorova, et al.
Published: (2015-08-01)

Epidemiological and etiological characteristics of community-acquired pneumonia in conscripts in the modern period. Comparative evaluation of the effectiveness of pneumococcal vaccines
by: P. V. Kulikov, et al.
Published: (2019-05-01)

CLINICAL-EPIDEMIOLOGICAL FEATURES AND OUTCOME OF GENERALIZED FORMS OF MENINGOCOCCAL INFECTION IN CHILDREN
by: G. P. Martynova, et al.
Published: (2017-10-01)

THE EFFICACY OF THE COSTS ON SEVERE RESPIRATORY SYNCYTIAL INFECTION PREVENTION WITH PALIVIZUMAB IN PRETERM INFANTS
by: A. V. Rudakova, et al.
Published: (2012-07-01)

Meningococcal Infection in Children in the Krasnoyarsk Territory: Analysis of Fatal Outcomes
by: G. P. Martynova, et al.
Published: (2015-10-01)

Cost analysis of the first line antiretroviral therapy in Russian Federation
by: A. V. Rudakova
Published: (2014-09-01)

Rare generalized form of meningococcal disease caused by Neisseria meningitidis serogroup W
by: L. N. Mazankova, et al.
Published: (2020-03-01)

Experience of Vaccination of a Patient with Systemic Juvenile Idiopathic Arthritis (sJIA) with a 13-Valent Pneumococcal Conjugate Vaccine, prior to the Appointment of Therapy with Tocilizumab, an Anti-IL-6-Receptor Monoclonal Antibody
by: Daria D. Vankova, et al.
Published: (2018-10-01)

An economic evaluation of vaccination in children against meningococcal infection in Moscow
by: S. V. Svetlichnaya, et al.
Published: (2023-10-01)

Meningococcal Infection in Novosibirsk: Changes in Epidemiology and Prevention Problems
by: I. Ya. Izvekova, et al.
Published: (2021-07-01)

The Level of Meningococcal Carriage and Genotyping of N. meningitidis Strains in the Group of Labor Migrants
by: M. A. Koroleva, et al.
Published: (2020-11-01)

Improving the therapy of generalized forms of Meningococcal infection in children using extracorporeal hemocorrection
by: K. V. Markova, et al.
Published: (2021-07-01)

Economic prognosis from vaccination against meningococcal infection inclusion into the National calendar of prophylactic vaccines in children of first age old
by: L. D. Popovich, et al.
Published: (2022-08-01)

Enhancing the National Vaccination Schedule in Russia
by: M. V. Fedoseenko
Published: (2015-12-01)

Immunization With a Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis Without Systemic Manifestations: a Prospective Study
by: Ekaterina I. Alexeeva, et al.
Published: (2018-01-01)

Clinical cases of meningococcal infection caused by Neisseria meningitidis serogroup W
by: N. V. Skripchenko, et al.
Published: (2019-11-01)

Meningococcal Urethritis: an additional Source of Meningococcal Disease?
by: N. N. Kostyukova, et al.
Published: (2020-07-01)

Immunological Efficacy and Safety of a New Pneumococcal Polysaccharide Conjugated Thirteen-Valent Vaccine in the Immunization of Adults and Children (Results of Clinical Studies in the Russian Federation)
by: I. V. Feldblium, et al.
Published: (2022-11-01)

PRACTICE OF EARLY REDUCED-ANTIGENIC-LOAD BCG-M VACCINATION OF HIV-EXPOSED INFANTS
by: S. N. Shugaeva, et al.
Published: (2015-08-01)

13-valent Pneumococcal Conjugate Vaccine and Haemophilus Influenzae-Tetanus Toxoid Conjugate Vaccine in Patient with Systemic Juvenile Idiopathic Arthritis Receiving Tocilizumab: Clinical Case
by: Ekaterina I. Alekseeva, et al.
Published: (2019-09-01)

Epidemiological Characteristics of Meningococcal Infection in Moscow
by: M. I. Gritsay, et al.
Published: (2020-05-01)